Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Iron isotope |
Is a |
False |
Iron |
Inferred relationship |
Some |
|
Focal hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Hemosiderosis, acquired |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Corneal rust ring |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Iron pigmentation of oral mucosa |
Causative agent |
True |
Iron |
Inferred relationship |
Some |
2 |
Serum iron measurement |
Has measured component |
False |
Iron |
Inferred relationship |
Some |
|
Total iron binding capacity |
Measures |
False |
Iron |
Inferred relationship |
Some |
|
Iron adverse reaction (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
bivirkning af jern og folsyre |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Polysaccharide iron complex adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Sodium ironedetate adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
bivirkning af kombinationspræparater med jern |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Iron sorbitol adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous salt adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
bivirkning af ferrofumerat |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous gluconate adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous glycine sulfate adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous succinate adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate adverse reaction |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous phosphate adverse reaction (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Red cell iron utilization study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
3 |
Total body iron with chelatable radioiron study |
Has measured component |
False |
Iron |
Inferred relationship |
Some |
|
Total body iron with chelatable radioiron study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Siderosis of eye |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
2 |
Iron measurement, liver tissue |
Has measured component |
False |
Iron |
Inferred relationship |
Some |
|
Iron kinetics study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Hereditary hemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Secondary hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Idiopathic pulmonary hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Iron measurement |
Has measured component |
False |
Iron |
Inferred relationship |
Some |
|
Iron measurement, urine |
Has measured component |
False |
Iron |
Inferred relationship |
Some |
|
argentosiderose |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
1 |
The early-onset and most severe form of hereditary hemochromatosis a group of diseases characterized by excessive tissue iron deposition of genetic origin. This juvenile form of hemochromatosis has the classical features of HH but is also characterized by severe cardiomyopathy and hypogonadism. Arthropathy, hepatic fibrosis, glucose intolerance, and increased skin pigmentation are frequent. Two types of the disease have been described, both being transmitted in an autosomal recessive way. |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Secondary hemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Restrictive cardiomyopathy secondary to hemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
undersøgelse af fordeling af radioaktivt jern i kroppen |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron overload |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Neonatal hemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Pulmonary siderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
1 |
African nutritional hemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Transfusion hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Shunt hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Erythropoietic hemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Dilated cardiomyopathy due to haemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Renal hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Hepatic hemosiderosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Hemochromatosis |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Radioiron oral absorption study |
Has measured component |
False |
Iron |
Inferred relationship |
Some |
|
Iron absorption measurement |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron clearance measurement |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron utilization measurement |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
24 hour urine iron output measurement |
Has measured component |
False |
Iron |
Inferred relationship |
Some |
|
Iron kinetics NOS |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Iron absorption measurement (procedure) |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Serum iron measurement |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Total body iron with chelatable radioiron study |
Component |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron measurement, liver tissue |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Iron measurement |
Component |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron measurement, urine |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Radioiron oral absorption study |
Component |
False |
Iron |
Inferred relationship |
Some |
|
24 hour urine iron output measurement |
Component |
False |
Iron |
Inferred relationship |
Some |
2 |
Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing iron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing iron dextran (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Iron-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing ferrous gluconate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing iron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
Oral iron for iron-deficiency anemias |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing precisely ferrous fumarate 305 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate 322 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate 210 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrofumarat 140 mg/5 ml sukkerfri syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrofumarat 140 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous gluconate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous glycine sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrocontin Continus 562.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous glycine sulfate 562.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous succinate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 60mg/5mL pediatric oral solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferrosulfat 150 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferrosulfat 325 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferrosulfat 116 mg/ml dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferrosulfat 160 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing folic acid and iron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron |
Inferred relationship |
Some |
1 |
ferrosulfat 150 mg + folsyre 500 µg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferrosulfat 325 mg + folsyre 350 µg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferriammoniumcitrat 80 mg/5 ml + folsyre 500 µg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferrosulfat 160 mg + folsyre 400 µg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
ferriammoniumcitrat + folsyre 80 mg/2,5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing sodium feredetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
kombinationspræparater med jern |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Parenteral form iron for iron-deficiency anemias |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
Product containing iron sorbitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
jernsorbitol (50 mg/ml ferrojern) injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
jernhydroxidsukrosekompleks |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|
jernhydroxidsukrosekompleks 100 mg/5 ml (Fe) infusionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron |
Inferred relationship |
Some |
|